Elandas and AccessSync Announce Merger

Mergers and AcquisitionsImage by Gerd Altmann

NEWTOWN, PA — Elandas, Inc. announced it recently merged with long-standing partner AccessSync, LLC. Together, Elandas and AccessSync leadership combine decades of experience delivering integrated market access planning and execution to accelerate growth in an increasingly complex biopharma market access environment.

“This merger is a major step forward in ensuring our technology allows key information to reach clients, health care professionals, and patients, where it will have maximum impact on access and outcomes,” said Ryan Roberts, CEO. “We are extremely excited to welcome the AccessSync team to Elandas.”

The new company’s vision is to ensure that innovative biopharma products reach appropriate patients through seamlessly connecting people, data, and resources.

“The Elandas technology platform introduces unrivaled speed and flexibility into this space, combining workflow and data automation with the ability to tailor each individual user experience to specific market access needs,” said Tate Rarick, Managing Director of AccessSync, Inc. “Coming together represents a milestone in our shared quest to unlock the full potential of our customers’ market access strategies through optimized planning and execution.”

A seamless, integrated approach to market access is becoming increasingly important. Specialty products now lead in new drug approvals and often involve complex coverage, distribution, and administration requirements. All these access elements interact, and in combination can significantly impact competitive positioning, office logistics, and patient affordability. There is an emerging need to demystify the market access execution pathway.

“The most exciting aspect of this merger is the ability to integrate data, creative, and technology to drive informed actions,” said Rarick. “Working with our clients and their partners, we can now fully leverage their organizational assets for maximum effectiveness, enabling customized execution down to local market and health care professional levels.”

READ:  QNB Corp. Declares Quarterly Dividend of $0.37 Per Share

As a result of the acquisition, AccessSync, LLC will become AccessSync, Inc., a wholly-owned US subsidiary of Elandas, Inc.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.